What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
Surgery, Breast cancer, Sentinel node, Nuclear medicine and Internal medicine are his primary areas of study.
His Surgery study combines topics from a wide range of disciplines, such as Axillary Lymph Node Dissection, Sentinel lymph node, Ibritumomab tiuxetan and Rituximab.
His Breast cancer course of study focuses on Metastasis and Survival rate.
His biological study spans a wide range of topics, including Lymphatic metastasis, Umbilicus, Biopsy, Dissection and Radionuclide imaging.
In the field of Nuclear medicine, his study on Positron emission tomography and Scintigraphy overlaps with subjects such as Radionuclide angiography.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Endocrinology and Oncology.
His most cited work include:
- Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes (1740 citations)
- A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. (1698 citations)
- Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. (704 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Nuclear medicine, Radiology, Radionuclide therapy and Oncology.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Radioimmunotherapy and Endocrinology.
His Radiology research includes themes of Lesion, Breast cancer, Sentinel node and Occult.
His study looks at the relationship between Breast cancer and fields such as Surgery, as well as how they intersect with chemical problems.
His biological study spans a wide range of topics, including Melanoma and Lymph node.
In his work, Cancer research is strongly intertwined with Neuroendocrine tumors, which is a subfield of Radionuclide therapy.
He most often published in these fields:
- Internal medicine (27.16%)
- Nuclear medicine (24.78%)
- Radiology (18.53%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (27.16%)
- Prostate cancer (7.97%)
- Oncology (17.03%)
In recent papers he was focusing on the following fields of study:
Giovanni Paganelli focuses on Internal medicine, Prostate cancer, Oncology, Radionuclide therapy and Neuroendocrine tumors.
His Internal medicine research focuses on subjects like Gastroenterology, which are linked to Toxicity.
The Oncology study combines topics in areas such as Biomarker, Androgen deprivation therapy, Breast cancer and Antigen.
His Radionuclide therapy study improves the overall literature in Nuclear medicine.
His Neuroendocrine tumors research incorporates themes from Cancer research, Octreotide, Cohort and Treatment response.
Giovanni Paganelli interconnects Lesion and Biopsy in the investigation of issues within Radiation therapy.
Between 2015 and 2021, his most popular works were:
- Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors (73 citations)
- Long-term results of PRRT in advanced bronchopulmonary carcinoid (57 citations)
- A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management (54 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
His primary areas of investigation include Internal medicine, Prostate cancer, Radionuclide therapy, Oncology and Nuclear medicine.
Internal medicine connects with themes related to Gastroenterology in his study.
He combines subjects such as Neuroendocrine tumors, Peptide receptor and Somatostatin receptor with his study of Radionuclide therapy.
His Neuroendocrine tumors research integrates issues from Octreotide and Bone marrow.
The concepts of his Oncology study are interwoven with issues in Odds ratio, Progressive disease, CAR T-cell therapy, Antigen and Biomarker.
His Nuclear medicine study combines topics in areas such as Kidney and Radiation therapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
